Medical Health Cluster

Prophylaxis

Posthospitalization VTE Prophylaxis for Some Patients with COVID-19

Low-dose rivaroxaban at discharge prevented some venous thromboembolism events at 1 month for high-risk patients. Therapeutic anticoagulation after hospital discharge does not benefit moderate-risk patients recovering from COVID-19 (NEJM JW Gen Med Aug 1 2021 and Lancet 2021; 397:2253), but whether high-risk patients might benefit is unclear. Brazilian investigators enrolled 320 patients (from […]

Read More

Prophylaxis against covid-19: living systematic review and network meta-analysis

Abstract Objective To determine and compare the effects of drug prophylaxis on SARS-CoV-2 infection and covid-19. Design Living systematic review and network meta-analysis. Data sources World Health Organization covid-19 database, a comprehensive multilingual source of global covid-19 literature to 25 March 2021, and six additional Chinese databases to 20 February 2021. Study selection Randomised […]

Read More